Patent Portfolio

Our Development Pipeline

In November 2018 we were awarded a patent for a phytocannabinoid formulation for pain. We have filed seven patents with the United States Patent and Trademark Office (“USPTO”) for indications of Alzheimer’s, Parkinson’s, seizures, and eating disorders.